{"id":525557,"date":"2021-01-06T16:58:01","date_gmt":"2021-01-06T16:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=525557"},"modified":"2021-01-06T16:58:01","modified_gmt":"2021-01-06T16:58:01","slug":"left-atrial-appendage-laa-closure-devices-market-to-cross-usd-3-billion-by-2025-arizton","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/left-atrial-appendage-laa-closure-devices-market-to-cross-usd-3-billion-by-2025-arizton_525557.html","title":{"rendered":"Left Atrial Appendage (LAA) Closure Devices Market to Cross USD 3 Billion by 2025 &#8211; Arizton"},"content":{"rendered":"<p style=\"text-align: justify;\">The <a rel=\"nofollow\" href=\"https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market\">left atrial appendage (LAA) closure devices&nbsp;market<\/a>&nbsp;is expected to grow at a staggering CAGR of over 36% during the period 2019&ndash;2025.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The left atrial appendage (LAA) closure devices market growth can be attributed to the growing prevalence of atrial fibrillation (AF) across the globe. The growth in the geriatric population and the increased prevalence of lifestyle-related disorders such as obesity, diabetics, and high blood pressure are contributing to the growth of AF. According to several epidemiological studies, AF is the most common arrhythmia, with an estimated prevalence of 1.5&ndash;3% in the general population in developed regions. Approximately 7.6 million people over 65 years of age in Europe suffered from AF in 2016, which is expected to increase by around 89%, reaching 14.4 million by 2060. Hence, the high occurrence of AF across the globe is likely to contribute to the growth of the market.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The following factors are likely to contribute to the growth of the left atrial appendage closure devices market during the forecast period:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Emergence of Advanced Imaging Modalities<\/li>\n<li>Increasing Focus on Conducting Clinical Trials on LAA Closure Devices<\/li>\n<li>Advent of Hybrid Approach in LAA Closure Technique<\/li>\n<li>Transference from Open to MI Surgeries<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The study considers the present scenario of the left atrial appendage closure devices market and its market dynamics for the period 2019&minus;2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market\">Get your free sample now!<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Left Atrial Appendage (LAA) Closure Devices Market &ndash; Vendor Profiles<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Vendors<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Boston Scientific<\/li>\n<li>AtriCure<\/li>\n<li>Abbott<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Other Vendors<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Biosense Webster<\/li>\n<li>Lifetech Scientific<\/li>\n<li>SentreHEART<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Investigational Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Append Medical<\/li>\n<ul>\n<li>Business Overview<\/li>\n<li>Key Strengths<\/li>\n<li>Key Strategies<\/li>\n<li>Key Opportunities<\/li>\n<\/ul>\n<li>Cardia<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Left Atrial Appendage (LAA) Closure Devices Market &ndash; Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Market Segmentation by Product<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Endocardial LAA Closures<\/li>\n<li>Epicardial LAA Closure<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Market Segmentation by End-user&nbsp; &nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Hospitals<\/li>\n<li>Specialty Cardiac Centers<\/li>\n<li>Ambulatory Surgery Centers (ASC)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Market Segmentation by Geography<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Europe<\/strong><\/li>\n<ul>\n<li>Spain<\/li>\n<li>Germany<\/li>\n<li>Italy<\/li>\n<li>France<\/li>\n<li>UK<\/li>\n<\/ul>\n<li><strong>North America<\/strong><\/li>\n<ul>\n<li>US<\/li>\n<li>Canada<\/li>\n<\/ul>\n<li><strong>APAC<\/strong><\/li>\n<ul>\n<li>South Korea<\/li>\n<li>China<\/li>\n<li>Japan<\/li>\n<li>Australia<\/li>\n<li>India<\/li>\n<\/ul>\n<li><strong>Latin America<\/strong><\/li>\n<ul>\n<li>Brazil<\/li>\n<li>Argentina<\/li>\n<li>Mexico<\/li>\n<\/ul>\n<li><strong>MEA<\/strong><\/li>\n<ul>\n<li>Turkey<\/li>\n<li>Saudi Arabia<\/li>\n<li>South Africa<\/li>\n<\/ul>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market\">Get your free sample now!<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Left Atrial Appendage (LAA) Closure Devices Market &ndash; Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>1 Research Methodology<br \/> 2 Research Objectives<br \/> 3 Research Process<\/p>\n<p> 4 Scope &amp; Coverage<\/strong><br \/> 4.1 Market Definition<br \/> 4.1.1 Inclusions<br \/> 4.1.2 Exclusion<br \/> 4.2 Base Year<br \/> 4.3 Scope Of The Study<br \/> 4.4 Market Segments<br \/> 4.4.1 Market Segmentation By Product<br \/> 4.4.2 Market Segmentation By End-User<br \/> 4.4.3 Market Segmentation By Geography<\/p>\n<p> <strong>5 Report Assumptions &amp; Caveats<\/strong><br \/> 5.1 Key Caveats<br \/> 5.2 Currency Conversion<br \/> 5.3 Market Derivation<\/p>\n<p> <strong>6 Market at a Glance<br \/> 7 Introduction<\/strong><br \/> 7.1 Atrial Fibrillation: Overview<br \/> 7.1.1 Background<br \/> 7.1.2 LAA Closure Devices For The Treatment Of AF<\/p>\n<p> <strong>8 Market Opportunities &amp; Trends<\/strong><br \/> 8.1 Emergence Of Advanced Imaging Modalities<br \/> 8.2 Vendors Increasing Focus On Conducting Clinical Trials On LAA Closure Devices<br \/> 8.3 Emergence Of Hybrid Approach In LAA Closure Technique<br \/> 8.4 Promising Investigational LAA Closure Devices<br \/> 8.5 Strategic Acquisitions<\/p>\n<p> <strong>9 Market Growth Enablers<\/strong><br \/> 9.1 Rising Incidence Of AF<br \/> 9.2 Transference From Open To Mi Surgeries<br \/> 9.3 Frequent Product Approval<br \/> 9.4 Significant Long-Term Cost Effectiveness Associated With LAA Closure<\/p>\n<p> <strong>10 Market Restraints<\/strong><br \/> 10.1 High Use Of Oral Drugs<br \/> 10.2 Complications Associated With LAA Closure Devices<br \/> 10.3 Stringent Regulations &amp; Product Recalls<\/p>\n<p> <strong>11 Market Landscape<\/strong><br \/> 11.1 Market Overview<br \/> 11.2 Market Size &amp; Forecast<br \/> 11.3 Five Forces Analysis<br \/> 11.3.1 Threat Of New Entrants<br \/> 11.3.2 Bargaining Power Of Suppliers<br \/> 11.3.3 Bargaining Power Of Buyers<br \/> 11.3.4 Threat Of Substitutes<br \/> 11.3.5 Competitive Rivalry<\/p>\n<p> <strong>12 Product<\/strong><br \/> 12.1 Market Snapshot &amp; Growth Engine<br \/> 12.2 Market Overview<br \/> 12.3 Endocardial LAA Closure<br \/> 12.3.1 Market Overview<br \/> 12.3.2 Market Size &amp; Forecast<br \/> 12.4 Epicardial LAA Closure<br \/> 12.4.1 Market Overview<br \/> 12.4.2 Market Size &amp; Forecast<\/p>\n<p> <strong>13 End-User<\/strong><br \/> 13.1 Market Snapshot &amp; Growth Engine<br \/> 13.2 Market Overview<br \/> 13.3 Hospitals<br \/> 13.3.1 Market Overview<br \/> 13.3.2 Market Size &amp; Forecast<br \/> 13.4 Specialty Cardiac Centers<br \/> 13.4.1 Market Overview<br \/> 13.4.2 Market Size &amp; Forecast<br \/> 13.5 ASCS<br \/> 13.5.1 Market Overview<br \/> 13.5.2 Market Size &amp; Forecast<\/p>\n<p> <strong>14 Geography<\/strong><br \/> 14.1 Market Snapshot &amp; Growth Engine<br \/> 14.2 Geographic Overview<\/p>\n<p> <strong>15 North America<\/strong><br \/> 15.1 Market Overview<br \/> 15.2 Market Size &amp; Forecast<br \/> 15.3 Key Countries<br \/> 15.3.1 US: Market Size &amp; Forecast<br \/> 15.3.2 Canada: Market Size &amp; Forecast<\/p>\n<p> <strong>16 Europe<\/strong><br \/> 16.1 Market Overview<br \/> 16.2 Market Size &amp; Forecast<br \/> 16.3 Key Countries<br \/> 16.3.1 Germany: Market Size &amp; Forecast<br \/> 16.3.2 France: Market Size &amp; Forecast<br \/> 16.3.3 UK: Market Size &amp; Forecast<br \/> 16.3.4 Spain: Market Size &amp; Forecast<br \/> 16.3.5 Italy: Market Size &amp; Forecast<\/p>\n<p> <strong>17 APAC<\/strong><br \/> 17.1 Market Overview<br \/> 17.2 Market Size &amp; Forecast<br \/> 17.3 Key Countries<br \/> 17.3.1 China: Market Size &amp; Forecast<br \/> 17.3.2 Japan: Market Size &amp; Forecast<br \/> 17.3.3 Australia: Market Size &amp; Forecast<br \/> 17.3.4 South Korea: Market Size &amp; Forecast<br \/> 17.3.5 India: Market Size &amp; Forecast<\/p>\n<p> <strong>18 Latin America<\/strong><br \/> 18.1 Market Overview<br \/> 18.2 Market Size &amp; Forecast<br \/> 18.3 Key Countries<br \/> 18.3.1 Brazil: Market Size &amp; Forecast<br \/> 18.3.2 Mexico: Market Size &amp; Forecast<br \/> 18.3.3 Argentina: Market Size &amp; Forecast<\/p>\n<p> <strong>19 Middle East &amp; Africa<\/strong><br \/> 19.1 Market Overview<br \/> 19.2 Market Size &amp; Forecast<br \/> 19.3 Key Countries<br \/> 19.3.1 Turkey: Market Size &amp; Forecast<br \/> 19.3.2 Saudi Arabia: Market Size &amp; Forecast<br \/> 19.3.3 South Africa: Market Size &amp; Forecast<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Looking for more information? <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market\">Click Here<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Arizton Advisory &amp; Intelligence<\/strong><\/p>\n<p style=\"text-align: justify;\">Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.<\/p>\n<p style=\"text-align: justify;\">Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize fool proof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including &ndash;Consumer Goods &amp; Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging<\/p>\n<p style=\"text-align: justify;\">Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.<\/p>\n<p style=\"text-align: justify;\">Arizton Advisory &amp; Intelligence<br \/> Chicago, Illinois, 60605<br \/> <strong>Mail:<\/strong>&nbsp;<a rel=\"nofollow\" href=\"mailto:enquiry@arizton.com\">enquiry@arizton.com<\/a><br \/> <strong>Call:<\/strong> +1-312-235-2040\/+1 302 469 0707<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/arizton.com_57647.html\" rel=\"nofollow\">Arizton Advisory &#038; Intelligence <\/a><br \/><strong>Contact Person:<\/strong> Jessica<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=left-atrial-appendage-laa-closure-devices-market-to-cross-usd-3-billion-by-2025-arizton\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 3122332770<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.arizton.com\/market-reports\/left-atrial-appendage-closure-devices-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=left-atrial-appendage-laa-closure-devices-market-to-cross-usd-3-billion-by-2025-arizton\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The left atrial appendage (LAA) closure devices&nbsp;market&nbsp;is expected to grow at a staggering CAGR of over 36% during the period 2019&ndash;2025. &nbsp; The left atrial appendage (LAA) closure devices market growth can be attributed to the growing prevalence of atrial &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/left-atrial-appendage-laa-closure-devices-market-to-cross-usd-3-billion-by-2025-arizton_525557.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-525557","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/525557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=525557"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/525557\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=525557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=525557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=525557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}